PHYH, or phytanoyl-CoA 2-hydroxylase, is a pivotal enzyme in the peroxisomal alpha-oxidation of fatty acids, particularly the branched-chain fatty acid, phytanic acid. This enzyme plays a crucial role in the catabolic pathway that prevents the accumulation of phytanic acid, which is found in dietary sources such as ruminant fats, dairy products, and certain fish. The process of alpha-oxidation, facilitated by PHYH, is essential for breaking down phytanic acid into pristanic acid, which can then undergo beta-oxidation, a more common fatty acid degradation pathway. The expression of PHYH is highly relevant within the context of cellular metabolism, as it ensures proper lipid homeostasis and prevents the toxic build-up of certain lipids within the body. Given its fundamental role in lipid metabolism, the expression of PHYH is tightly regulated and can be influenced by various endogenous and exogenous compounds that interact with lipid metabolism pathways.
Certain dietary components and metabolites have been identified as potential activators that could induce the expression of PHYH. Compounds such as fibrate drugs (e.g., bezafibrate), which are known to activate peroxisome proliferator-activated receptors (PPARs), can initiate a cascade of events leading to the upregulation of genes involved in fatty acid oxidation, including PHYH. Similarly, polyunsaturated fatty acids like eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may exert their effects through PPAR-mediated mechanisms, suggesting a potential to enhance PHYH expression. Oxysterols such as 25-hydroxycholesterol can interact with liver X receptors (LXRs), which are nuclear receptors that play a key role in cholesterol and lipid metabolism, consequently promoting the transcription of lipid-processing enzymes. Phytol, a diterpene alcohol found in chlorophyll, may lead to the upregulation of PHYH as it is metabolized into phytanic acid, thus providing feedback for its own catabolism. Additionally, bile acids such as lithocholic acid and cholic acid can stimulate the expression of various enzymes involved in lipid metabolism, which may include PHYH. This elaborate interplay of dietary components and metabolic by-products with gene expression mechanisms underscores the complex regulation of PHYH and highlights the potential for certain molecules to act as inducers of its expression, thereby modulating the biochemical pathways of lipid metabolism.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate, through its action as a fibrate drug, can activate PPARα, leading to the transcriptional upregulation of genes involved in fatty acid metabolism, potentially including the peroxisomal enzyme PHYH. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a selective PPARγ agonist, can stimulate the expression of genes involved in adipogenesis and lipid homeostasis, which may lead to a secondary upsurge in PHYH expression to cope with the altered lipid profile. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a thiazolidinedione and PPARγ agonist, can stimulate fatty acid storage and glucose metabolism pathways, which may necessitate an increase in PHYH expression for lipid processing and maintenance of homeostasis. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
Leukotriene B4, through its role as an inflammatory mediator, can activate nuclear receptors and signaling pathways that may upregulate the expression of genes associated with lipid metabolism, including PHYH, to counteract the effects of inflammation. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $53.00 $91.00 $169.00 $474.00 | 8 | |
25-hydroxycholesterol, being an oxysterol, can interact with liver X receptors (LXRs), which may result in the upregulated transcription of genes involved in cholesterol and lipid metabolism, potentially including PHYH. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
EPA, by acting on PPARs and other transcription factors involved in lipid metabolism, can enhance the expression of enzymes necessary for the catabolism of fatty acids, which may include the induction of PHYH expression. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
DHA, as an influential omega-3 fatty acid, may stimulate the expression of genes involved in peroxisomal lipid metabolism by engaging PPARs, which could lead to increased PHYH expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, by serving as an agonist for retinoic acid receptors (RARs), can induce the expression of genes involved in cell differentiation and lipid metabolism, which may include a stimulatory effect on PHYH gene transcription. | ||||||
Lithocholic acid | 434-13-9 | sc-215262 sc-215262A | 10 g 25 g | $100.00 $272.00 | 1 | |
Lithocholic acid, a secondary bile acid, can induce the expression of detoxification enzymes in the liver, and could similarly lead to the upregulation of PHYH as part of the cellular adaptation to increased bile acid synthesis. | ||||||
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $49.00 $123.00 $578.00 $1018.00 $4570.00 | 11 | |
Cholic acid, a primary bile acid, can stimulate the expression of enzymes involved in its own metabolism and may consequently lead to the upregulation of PHYH, which is implicated in the breakdown of branched fatty acids. | ||||||